menu
    • menu

    Company profile for Allorion Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Allorion Therapeutics, We focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug development. We believe in a more precise future of targeted therapies and an extended reach of precision medicine to more patients. We want to stay at new frontiers of drug development by leveraging the delineations of human genomes and breakthroughs in dr...
    Allorion Therapeutics, We focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug development. We believe in a more precise future of targeted therapies and an extended reach of precision medicine to more patients. We want to stay at new frontiers of drug development by leveraging the delineations of human genomes and breakthroughs in drug design.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Allorion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    22 Strathmore Rd, Natick, MA 01760
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alloriontx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alloriontx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Geopolitics threatens Chinese biotechs' hot out-licensing biz
    Geopolitics threatens Chinese biotechs' hot out-licensing biz

    10 Apr 2024

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chinese-biotechs-out-licensing-business-scorching-hot-could-geopolitics-rain-their-parade

    Max Bayer FIERCE BIOTECH
    10 Apr 2024
    Share Share
    Allorion scores second deal of the week in $1B pact with Avenzo
    Allorion scores second deal of the week in $1B pact with Avenzo

    05 Jan 2024

    // PRESS RELEASE

    https://avenzotx.com/press-releases/avenzo-therapeutics-announces-global-license-of-avzo-021-arts-021-a-potentially-best-in-class-clinical-stage-cdk2-inhibitor-from-allorion-therapeutics/

    PRESS RELEASE
    05 Jan 2024
    Share Share
    AstraZeneca adds another China-originated cancer drug to pipeline
    AstraZeneca adds another China-originated cancer drug to pipeline

    03 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allorion-therapeutics-announces-exclusive-option-and-global-license-agreement-for-novel-preclinical-stage-egfr-l858r-allosteric-inhibitor-program-with-astrazeneca-302023562.html

    PR NEWSWIRE
    03 Jan 2024
    Share Share
    Crystal Pharmatech Recognized as
    Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics

    07 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/crystal-pharmatech-recognized-as-best-partner-by-allorion-therapeutics-for-excellent-services-301871891.html

    PR NEWSWIRE
    07 Jul 2023
    Share Share
    Allorion raises $50M Series B; AskBio gets a new CEO
    Allorion raises $50M Series B; AskBio gets a new CEO

    10 Mar 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/allorion-raises-50m-series-b-askbio-gets-a-new-ceo/

    Katherine Lewin ENDPTS
    10 Mar 2023
    Share Share
    Allorion Therapeutics raises $50 million Series B financing
    Allorion Therapeutics raises $50 million Series B financing

    09 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allorion-therapeutics-a-next-generation-precision-medicine-company-focusing-on-oncology-and-autoimmune-diseases-raises-50-million-series-b-financing-301767570.html

    PR NEWSWIRE
    09 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search